๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma

โœ Scribed by Dowell, Jonathan E.; Dunphy, Frank R.; Taub, Robert N.; Gerber, David E.; Ngov, Likheng; Yan, Jingsheng; Xie, Yang; Kindler, Hedy Lee

Book ID
118247644
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
249 KB
Volume
77
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase II study of VP-16 and cisplatin
A phase II study of VP-16 and cisplatin in patients with unresectable malignant mesothelioma
โœ Elizabeth A. Eisenhauer; William K. Evans; Nevin Murray; Walter Kocha; Rafal Wie ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer US ๐ŸŒ English โš– 204 KB

The National Cancer Institute of Canada (NCIC) Clinical Trials Group has carried out a phase II study of VP-16 100 mg/m 2 daily x 3 and cisplatin 25 mg/m 2 daily x 3 in untreated patients with malignant mesothelioma. Twenty-seven eligible patients were entered on the trial and the majority had pleur